scholarly article | Q13442814 |
P2093 | author name string | Bipin N Savani | |
Minoo Battiwalla | |||
Pamela Stratton | |||
Tajana Klepac Pulanic | |||
Dana Shanis | |||
Melissa Merideth | |||
P2860 | cites work | What works? Evidence for lifestyle and nonprescription therapies in menopause | Q84151608 |
Use of high-risk human papillomavirus testing in patients with low-grade squamous intraepithelial lesions | Q84511415 | ||
Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age | Q28240228 | ||
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions | Q28301685 | ||
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey | Q29391755 | ||
Mind-body therapies for menopausal symptoms: a systematic review. | Q30432169 | ||
Preservation of fertility in patients with cancer | Q34081146 | ||
Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination | Q34158682 | ||
Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment | Q34283958 | ||
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report | Q34474243 | ||
Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study | Q34554733 | ||
Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer | Q34592774 | ||
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases | Q34627305 | ||
How I treat late effects in adults after allogeneic stem cell transplantation | Q34707208 | ||
Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality | Q35154918 | ||
Consequences and treatment of ovarian failure after total body irradiation for leukaemia | Q35719712 | ||
Maintenance of ovarian function and risk of premature menopause related to cancer treatment | Q36077605 | ||
Impact of cancer treatment on uterine function. | Q36077648 | ||
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study | Q36141716 | ||
Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years | Q36407114 | ||
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Wo | Q36424524 | ||
Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management | Q36538413 | ||
Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management | Q36585735 | ||
Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review | Q36654839 | ||
Challenges and pitfalls in prenatal screening in pregnancies involving allogeneic stem cell transplantation recipients | Q36740113 | ||
Long-term endocrine sequelae of childhood cancer | Q36881328 | ||
Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure | Q36896854 | ||
Ovarian recovery after stem cell transplantation | Q36977555 | ||
Labial fusion: a rare complication of chronic graft-versus-host disease | Q37045511 | ||
Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility | Q37079607 | ||
Solid cancers after allogeneic hematopoietic cell transplantation | Q37082013 | ||
Endocrinological late complications after hematopoietic SCT in children | Q37188477 | ||
Vaccination after stem cell transplant: a review of recent developments and implications for current practice | Q37204838 | ||
Gynecologic care in hematopoietic stem cell transplant patients: a review | Q37823687 | ||
Severe vaginal chronic graft-versus-host disease (GVHD): two cases with late onset and literature review. | Q37841491 | ||
Drug-induced DNA damage and tumor chemosensitivity | Q37981691 | ||
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years | Q38383523 | ||
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial | Q38487646 | ||
Influence of treatment of erosive lichen planus of the vulva on its prognosis | Q39353476 | ||
Acupuncture for hot flushes in perimenopausal and postmenopausal women: a randomised, sham-controlled trial. | Q39741596 | ||
Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study | Q40310163 | ||
Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles | Q40575690 | ||
Ovarian function following marrow transplantation for aplastic anemia or leukemia | Q42208869 | ||
Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood | Q42457000 | ||
Prospective study of pituitary-gonadal function to evaluate short-term effects of ablative chemotherapy or total body irradiation with autologous or allogenic marrow transplantation in post-menarcheal female patients | Q42496333 | ||
Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation | Q42537792 | ||
HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection | Q43681620 | ||
Loss of seroreactivity against human papillomavirus (HPV) in bone marrow transplant recipients | Q43811547 | ||
Treatment of vulvovaginal lichen planus with vaginal hydrocortisone suppositories | Q44084906 | ||
HPV6b virus like particles are potent immunogens without adjuvant in man. | Q44456772 | ||
Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. | Q46011923 | ||
Endocrine disorders during the first year after autologous stem-cell transplant | Q46515962 | ||
Function of the hypothalamic-pituitary-gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases | Q46622312 | ||
Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus | Q46687330 | ||
Solid cancers after bone marrow transplantation | Q47582581 | ||
Ovarian function after autologous bone marrow transplantation | Q47625360 | ||
Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms | Q48509031 | ||
Gender-associated differences in the quality of life after allogeneic BMT. | Q48682043 | ||
Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation. | Q51729506 | ||
Part 1: Hormone replacement for survivors of childhood cancer with ovarian failure--when is it worth the risk? | Q53428969 | ||
Quality of life in 244 recipients of allogeneic bone marrow transplantation. | Q53512272 | ||
Cyclophosphamide-Induced Ovarian Failure | Q69612087 | ||
Unanticipated pregnancy with intrauterine growth retardation after radiation-induced ovarian failure. A case report | Q71308035 | ||
Gynecologic manifestations of chronic graft-versus-host disease | Q71441336 | ||
Successful pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocol | Q72033468 | ||
Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: long-term follow up of 79 females | Q72892127 | ||
Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial | Q73042458 | ||
Gonadal function after bone marrow transplantation for acute leukemia during childhood | Q73093068 | ||
Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group | Q73217522 | ||
Early high dose chemotherapy intensification with autologous bone marrow transplantation in lymphoma associated with retention of fertility and normal pregnancies in females. Scotland and Newcastle Lymphoma Group, UK | Q74303453 | ||
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial | Q74389035 | ||
Hormone replacement therapy and chronic graft-versus-host disease activity in women treated with bone marrow transplantation for hematologic malignancies | Q74452886 | ||
Placenta percreta and uterine rupture associated with prior whole body radiation therapy | Q77157107 | ||
Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure | Q77668861 | ||
Treatment of vaginal agglutination associated with chronic graft-versus-host disease | Q78467997 | ||
Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation | Q79157140 | ||
ACOG Practice Bulletin no. 109: Cervical cytology screening | Q82793091 | ||
Quality of life, reproduction and sexuality after stem cell transplantation with partially T-cell-depleted grafts and after conditioning with a regimen including total body irradiation | Q82879874 | ||
Clinical and biologic evaluation of ovarian function in women treated by bone marrow transplantation for various indications during childhood or adolescence | Q84058809 | ||
P433 | issue | 1 | |
P304 | page(s) | 83-93 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | Seminars in Hematology | Q15765535 |
P1476 | title | Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management | |
P478 | volume | 49 |
Q36455544 | A Rare Consequence of Chronic Graft Versus Host Disease - Peyronie's Disease |
Q47802409 | A mindfulness-based program for improving quality of life among hematopoietic stem cell transplantation survivors: feasibility and preliminary findings. |
Q40021759 | A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia. |
Q38643563 | Acute pain crisis in a patient with sickle cell disease undergoing ovarian simulation for fertility preservation prior to curative stem cell transplantation: case report and literature review |
Q95643021 | Basic fibroblast growth factor and agarose gel promote the ability of immune privilege of allogeneic cartilage transplantation in rats |
Q36471739 | Chronic Myeloid Leukaemia: A paradigm for malignancy or just a strange disease? |
Q38262917 | Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD. |
Q38772931 | Clinical management of genital chronic GvHD. |
Q35201332 | Dexrazoxane abrogates acute doxorubicin toxicity in marmoset ovary |
Q91820312 | Female genital tract chronic graft-versus-host disease: A narrative review |
Q42350318 | Gynecologic care after hematopoietic cell transplantation: a call to action to include gynecologists in the transplant team |
Q36087035 | Hormone Use for Therapeutic Amenorrhea and Contraception During Hematopoietic Cell Transplantation |
Q37174192 | How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer. |
Q34741675 | Human papillomavirus reactivation following treatment of genital graft-versus-host disease |
Q38798042 | Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care |
Q94948687 | Management and long-term consequences of genital graft versus host disease following hematopoietic stem cell transplantation |
Q36554724 | Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group repor |
Q35085226 | National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report |
Q90198165 | Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: a systematic review and meta-analysis |
Q47796311 | Sleepiness, Fatigue, Behavioral Functioning, and Quality of Life in Survivors of Childhood Hematopoietic Stem Cell Transplant |
Q33623863 | Vulvar and Vaginal Graft versus Host Disease: A Healthcare Clinic Initiative |